Abhishek Rao(@abhi16446) 's Twitter Profile Photo

Neuland Labs - gets USFDA approval for Aripiprazole Anhydrous which is widely used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder.

Lab

Neuland Labs - gets USFDA approval for Aripiprazole Anhydrous which is widely used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder. 

#Neuland #NeulandLab
account_circle
Sharad Dubey(@Sharad9Dubey) 's Twitter Profile Photo

NATCO PHARMA

Submits ANDA for migraine drug to USFDA

Drug had recorded sales of $908 million in the US market in 2023

account_circle
Dr Amol Akhade(@SuyogCancer) 's Twitter Profile Photo

USFDA rejects another China 🇨🇳 Made IO inspite of wide separation of OS curves . Camrelizumb plus Rivoceranib combination for Advanced HCC is rejected by U.S. FDA . Free HOME Run for Atezolizumab plus bev ? 🤔 Tanios Bekaii-Saab, MD Axel Grothey

USFDA rejects another China 🇨🇳 Made IO  inspite  of  wide separation of OS curves . Camrelizumb plus Rivoceranib combination for Advanced HCC is rejected by @US_FDA . Free HOME Run for Atezolizumab plus bev ?  🤔 @GIcancerDoc @agrothey
account_circle
AoI Ventures(@aoiventures) 's Twitter Profile Photo

💊Strides Pharma Science Ltd💊

gets USFDA approval for Sucralfate Oral Suspension!

📈 Market Size in US: ~$124 Mn (per IQVIA, March 2024)

Sucralfate Oral Suspension is primarily used for the treatment of:
🟠Active Duodenal Ulcers
🟠Gastric Ulcers
🟠Gastroesophageal

💊Strides Pharma Science Ltd💊

#Strides gets USFDA approval for Sucralfate Oral Suspension! 

📈 Market Size in US: ~$124 Mn (per IQVIA, March 2024)

Sucralfate Oral Suspension is primarily used for the treatment of:
🟠Active Duodenal Ulcers
🟠Gastric Ulcers
🟠Gastroesophageal
account_circle
ScoutQuest(@scoutquest) 's Twitter Profile Photo

| 📌 Laurus Labs Limited clarified the USFDA inspection at its subsidiary, LSPL, and the untitled letter. LSPL is not a material subsidiary, contributes less than 1% of consolidated revenues, and has not filed any US DMFs.

Details: sqst.in/ysn1p

⚡ AI

account_circle
Business Today बाज़ार(@BT_Bazaar) 's Twitter Profile Photo

आंखों की पुतली को फैलाने के लिए arm को Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride Ophthalmic के लिए मंज़ूरी मिली।

आंखों की पुतली को फैलाने के लिए #CaplinPoint arm को Abbreviated New Drug Application (ANDA) Phenylephrine  Hydrochloride Ophthalmic  के लिए #USFDA मंज़ूरी मिली।

#stock #sharemarket #business #news #marketupdates #trending
account_circle
CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

CEO, Satyanarayana Chava is confident of strong growth in CDMO business this year

Here's more from the interview with Sonia Shenoy , Prashant Nair and Nigel D'Souza 👇

cnbctv18.com/india/healthca…

#LaurusLabs CEO, Satyanarayana Chava is confident of strong growth in CDMO business this year 

Here's more from the interview with @_soniashenoy , @_prashantnair and @Nigel__DSouza 👇

cnbctv18.com/india/healthca…
account_circle
DrSuparujหมอรุจชวนคุย(@DrSuparuj) 's Twitter Profile Photo

🔬Update from AMWC 2024
ตัวอย่างผลการรักษาสิวด้วยเครื่อง เลเซอร์ซึ่งจำเพาะกับต่อมไขมัน AviClear จากงานวิจัยโดย Dr. Michael Gold ครับ

เลเซอร์รักษาสิว 1726 nm laser  (Aviclear, Cutera) เป็นเลเซอร์ล่าสุดที่ได้รับการรับรองจาก USFDA สามารถยับยั้งการทำงานของต่อมไขมัน

🔬Update from AMWC 2024
ตัวอย่างผลการรักษาสิวด้วยเครื่อง เลเซอร์ซึ่งจำเพาะกับต่อมไขมัน AviClear จากงานวิจัยโดย Dr. Michael Gold ครับ 

เลเซอร์รักษาสิว 1726 nm laser  (Aviclear, Cutera) เป็นเลเซอร์ล่าสุดที่ได้รับการรับรองจาก USFDA สามารถยับยั้งการทำงานของต่อมไขมัน
account_circle
Arka Bhattacharjee(@niveyshak) 's Twitter Profile Photo



✍️Company is investing in expanding and upgrading their facilities, with a goal to obtain USFDA approval for their Beta lactam plant next year.

✍️ A new API plant in Panoli is pending approval from the Pollution Control Board, which was delayed due to elections but is

#Kopran

✍️Company is investing in expanding and upgrading their facilities, with a goal to obtain USFDA approval for their Beta lactam plant next year. 

✍️ A new API plant in Panoli is pending approval from the Pollution Control Board, which was delayed due to elections but is
account_circle
CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

Dahej unit observations accessed by CNBC-TV18: Details here 🔎

Read here to know more👇
cnbctv18.com/market/sun-pha…

-Hormaz Fatakia ✒️

#SunPharma Dahej unit observations accessed by CNBC-TV18: Details here 🔎

Read here to know more👇
cnbctv18.com/market/sun-pha…

-@hormaz_fatakia ✒️
account_circle
ET NOW(@ETNOWlive) 's Twitter Profile Photo

Stocks In News | Laurus Labs receives letter from USFDA; letter format looks like that of warning letter

Stocks In News | Laurus Labs receives letter from USFDA; letter format looks like that of warning letter
account_circle
PHARMAHUBNG(@pharmahub_NG) 's Twitter Profile Photo

●Plerixafor Injection. It's intended for patients with non-Hodgkin's lymphoma or multiple myeloma

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for plerixafor injection single-dose vial product.

●Plerixafor Injection. It's intended for patients with non-Hodgkin's lymphoma or multiple myeloma

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for plerixafor injection single-dose vial product.

#Pharmanews
account_circle
CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

issued untitled letter to , dated May 16, 2024, letter deals with Drug Manufacturing Facility Laurus Synthesis located in AP

US FDA says they reviewed Laurus’s response in January 2024 & observed following deviations 👇

#USFDA issued untitled letter to #LaurusLabs, dated May 16, 2024, letter deals with Drug Manufacturing Facility Laurus Synthesis located in AP

US FDA says they reviewed Laurus’s response in January 2024 & observed following deviations 👇
account_circle